Schreiber G - Search Results

1

Gelatin Stabilizes Nebulized Proteins in Pulmonary Drug Delivery against COVID-19.

Li C, Marton I, Harari D, Shemesh M, Kalchenko V, Pardo M, Schreiber G, Rudich Y. Li C, et al. Among authors: schreiber g. ACS Biomater Sci Eng. 2022 Jun 13;8(6):2553-2563. doi: 10.1021/acsbiomaterials.2c00419. Epub 2022 May 24. ACS Biomater Sci Eng. 2022. PMID: 35608934 Free PMC article.

2

Stochastic receptor expression determines cell fate upon interferon treatment.

Levin D, Harari D, Schreiber G. Levin D, et al. Among authors: schreiber g. Mol Cell Biol. 2011 Aug;31(16):3252-66. doi: 10.1128/MCB.05251-11. Epub 2011 Jun 20. Mol Cell Biol. 2011. PMID: 21690295 Free PMC article.

3

Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligands.

Apelbaum A, Yarden G, Warszawski S, Harari D, Schreiber G. Apelbaum A, et al. Among authors: schreiber g. Mol Cell Biol. 2013 Feb;33(4):800-14. doi: 10.1128/MCB.01430-12. Epub 2012 Dec 10. Mol Cell Biol. 2013. PMID: 23230268 Free PMC article.

4

Bridging the species divide: transgenic mice humanized for type-I interferon response.

Harari D, Abramovich R, Zozulya A, Smith P, Pouly S, Köster M, Hauser H, Schreiber G. Harari D, et al. Among authors: schreiber g. PLoS One. 2014 Jan 9;9(1):e84259. doi: 10.1371/journal.pone.0084259. eCollection 2014. PLoS One. 2014. PMID: 24416207 Free PMC article.

5

Enhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosis.

Harari D, Kuhn N, Abramovich R, Sasson K, Zozulya AL, Smith P, Schlapschy M, Aharoni R, Köster M, Eilam R, Skerra A, Schreiber G. Harari D, et al. Among authors: schreiber g. J Biol Chem. 2014 Oct 17;289(42):29014-29. doi: 10.1074/jbc.M114.602474. Epub 2014 Sep 5. J Biol Chem. 2014. PMID: 25193661 Free PMC article.

6

A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis.

Harari D, Orr I, Rotkopf R, Baranzini SE, Schreiber G. Harari D, et al. Among authors: schreiber g. Hum Mol Genet. 2015 Jun 1;24(11):3192-205. doi: 10.1093/hmg/ddv071. Epub 2015 Feb 26. Hum Mol Genet. 2015. PMID: 25721402

7

Fine Tuning of a Type 1 Interferon Antagonist.

Urin V, Levin D, Sharma N, Harari D, Schreiber G. Urin V, et al. Among authors: schreiber g. PLoS One. 2015 Jul 9;10(7):e0130797. doi: 10.1371/journal.pone.0130797. eCollection 2015. PLoS One. 2015. PMID: 26158644 Free PMC article.

8

CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells.

Urin V, Shemesh M, Schreiber G. Urin V, et al. Among authors: schreiber g. J Mol Biol. 2019 Aug 9;431(17):3324-3338. doi: 10.1016/j.jmb.2019.06.007. Epub 2019 Jun 15. J Mol Biol. 2019. PMID: 31207241

9

The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19.

Schreiber G. Schreiber G. Front Immunol. 2020 Sep 30;11:595739. doi: 10.3389/fimmu.2020.595739. eCollection 2020. Front Immunol. 2020. PMID: 33117408 Free PMC article. Review.

10

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.

Zahradník J, Marciano S, Shemesh M, Zoler E, Harari D, Chiaravalli J, Meyer B, Rudich Y, Li C, Marton I, Dym O, Elad N, Lewis MG, Andersen H, Gagne M, Seder RA, Douek DC, Schreiber G. Zahradník J, et al. Among authors: schreiber g. Nat Microbiol. 2021 Sep;6(9):1188-1198. doi: 10.1038/s41564-021-00954-4. Epub 2021 Aug 16. Nat Microbiol. 2021. PMID: 34400835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

802 results

Search Page